The Biotechnology Industry Partnership Programme (BIPP) was launched on 5th December 2008. BIPP is a government partnership with Industries for support on a cost-sharing basis for path-breaking research in frontier futuristic technology areas having major economic potential and making the Indian industry globally competitive. It is focused on IP creation with ownership retained by Indian industry and wherever relevant, by collaborating scientists.
Thematic areas: Drugs including drug Delivery, Vaccines and clinical trials, Biosimilars & stem cells, Devices & Diagnostics, Agriculture, Industrial Biotechnology including Secondary Agriculture, and Bioinformatics & facilities that virtually cover every aspect of Biotechnology.
Unique features of the scheme:
Support for high risk, accelerated technology development, especially in futuristic technologies.
Support for very high risk, nationally and socially relevant areas, with no assured market. This would be more of translational research in such cases. It is envisaged that public institutes would be useful partners so that the basic R&D leads can be translated to product development by the industry.
Provides for product evaluation and validation through support for limited and large-scale field trials for agriculture products and clinical trials (Phase I, II, III) for health care products.
Supporting research project for novel IP generation.
For more details visit: https://www.birac.nic.in/desc_new.php?id=216